Edge Therapeutics, Inc.·4

Aug 15, 7:45 AM ET

Faleck Herbert J 4

4 · Edge Therapeutics, Inc. · Filed Aug 15, 2018

Insider Transaction Report

Form 4
Period: 2018-08-14
Faleck Herbert J
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2018-08-14+59,83359,833 total
    Common Stock (59,833 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
  • [F2]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
  • [F3]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT